Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development

Journal of Clinical Investigation

Volumn 112, Issue 5, 2003, Pages 659-669

  Zimmermann, Ralf C ^a,c   Hartman, Tipton ^a   Kavic, Suzanne ^a   Pauli, Samuel A ^a   Bohlen, Peter ^b   Sauer, Mark V ^a   Kitajewski, Jan ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ESTRONE; GONADOTROPIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ENDOTHELIAL CELL GROWTH FACTOR; ESTRADIOL; LYMPHOKINE; PROGESTERONE; SERIC GONADOTROPIN; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; HYPOPHYSECTOMY; MOUSE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL DIVISION; GROWTH, DEVELOPMENT AND AGING; OVARY FOLLICLE; PHYSIOLOGY; RAT; VASCULARIZATION;

ANIMALS; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; FEMALE; GONADOTROPINS, EQUINE; HYPOPHYSECTOMY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OVARIAN FOLLICLE; PROGESTERONE; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0141612009     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200318740     Document Type: Article

References (27)

1. Geva, E., and Jaffe, R.B. 2000. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil. Steril. 74:429-438.
2. Wulff, C., Wiegand, S.J., Saunders, P.T., Scobie, G.A., and Fraser, H.M. 2001. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)). Endocrinology. 142:3244-3254.
3. Geva, E., and Jaffee, R.B. 2000. Role of angiopoietins in reproductive tract angiogenesis. Obstet. Gynecol. Surv. 55:511-519.
4. Maisonpierre, P.C., et al. 1937. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:55-60.
5. Wulff, C., Wilson, H., Wiegand, S.J., Rudge, J.S., and Fraser, H.M. 2002. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology. 143:2797-2807.
6. Zimmermann, R.C., et al. 2001. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. J. Clin. Endocrinol. Metab. 86:768-772.
7. Zimmermann, R.C., Xiao, E., Bohlen, P., and Ferin, M. 2002. Administration of anti-vascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey. Endocrinology. 143:2496-2502.
8. Ferrara, N., Gerber, H.-P., and LeCouter, J. 2003. The biology of VEGF and its receptors. Nat. Med. 9:669-676.
9. McGee, E.A., and Hsueh, A.J. 2000. Initial and cyclic recruitment of ovarian follicles. Endocr. Rev. 21:200-214.
10. Halpin, D.M., and Charlton, H.M. 1988. Effects of short-term injection of gonadotrophins on ovarian follicle development in hypogonadal (hpg) mice. J. Reprod. Fertil. 82:393-400.
11. Wang, X.N., and Greenwald, G.S. 1993. Hypophysectomy of the cyclic mouse. II. Effects of follicle-stimulating hormone (FSH) and luteinizing hormone on folliculogenesis, FSH and human chorionic gonadotropin receptors, and steroidogenesis. Biol. Reprod. 48:595-605.
12. Wang, X.N., and Greenwald, G.S. 1993. Hypophysectomy of the cyclic mouse. I. Effects on folliculogenesis, oocyte growth, and follicle-stimulating hormone and human chorionic gonadotropin receptors. Biol. Reprod. 48:585-594.
13. Zimmermann, R.C., Hartman, T., Bohlen, P., Sauer, M.V., and Kitajewski, J. 2001. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea. Microvasc. Res. 62:15-25.
14. Pedersen, T., and Peters, H. 1968. Proposal for a classification of oocytes and follicles in the mouse ovary. J. Reprod. Fertil. 17:555-557.
15. Hsueh, A.J., Billig, H., and Tsafriri, A. 1994. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr. Rev. 15:707-724.
16. Vecchi, A., et al. 1994. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell. Biol. 63:247-254.
17. Pedersen, T. 1970. Follicle kinetics in the ovary of the cyclic mouse. Acta Endocrinol. (Copenh). 64:304-323.
18. Gomez, R., Simon, C., Remohi, J., and Pellicer, A. 2002. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology. 143:4339-4348.
19. Shweiki, D., Itin, A., Neufeld, G., Gitay-Goren, H., and Keshet, E. 1993. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest. 91:2235-2243.
20. Neulen, J., et al. 1998. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol. Hum. Reprod. 4:203-206.
21. Ferrara, N., and Davis-Smyth, T. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4-25.
22. Thurston, G., et al. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 286:2511-2514.
23. Thurston, G., et al. 2000. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6:460-463.
24. LeCouter, J., et al. 2001. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature. 412:877-884.
25. McConnell, N.A., et al. 2002. Water permeability of an ovarian antral follicle is predominantly transcellular and mediated by aquaporins. Endocrinology. 143:2905-2912.
26. Palumbo, A., and Yeh, J. 1994. In situ localization of apoptosis in the rat ovary during follicular atresia. Biol. Reprod. 51:888-895.
27. Hazzard, T.M., and Stouffer, R.L. 2000. Angiogenesis in ovarian follicular and luteal development. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 14:883-900.